This Viewpoint discusses the National Patient Safety Foundation’s report Free From Harm: Accelerating Patient Safety Improvement 15 Years After “To Err Is Human” and whether the recommendations achieve total systems safety.
This Viewpoint discusses the problem of disruptive behavior among physicians and offers guidance for developing a medical culture of safety with clear expectations and standards.
This Viewpoint discusses the need for physicians to develop cultural competence in firearm safety counseling as a strategy to improve patient and public health.
This phase 1 randomized clinical trial investigated the safety and tolerability of 2 vaccines against Ebola virus: an adenovirus type 26 vector vaccine encoding Ebola glycoprotein (Ad26.ZEBOV) and a modified vaccinia Ankara vector vaccine encoding glycoproteins from Ebola virus, Sudan virus, Marburg virus, and Tai Forest virus nucleoprotein (MVA-BN-Filo).
This Viewpoint discusses declines in hospital rates of patient harms between 2010 and 2014 and the efforts required to continue systematic nationwide improvement in safety.
This Viewpoint discusses the increasing adoption of digital health technology and how it may be helpful for policy makers, health care administrators, and clinical leaders.